GlassScriptPhysician profile
Cathlyn H Anderson
NPI 1023030269
$7,648.80
in general payments reported to CMS, 2019-2025
49 companies · $1,555 in 2025
The $1,555 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,057 · 2020: $777 · 2021: $547 · 2022: $1,452 · 2023: $1,444 · 2024: $816 · 2025: $1,555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,756 · Gift: $59.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,755.66 |
| Gift | $59.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,678.69 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $1,190.30 | 2020-2025 | Freestyle Libre 3, Proclaim |
| Astrazeneca Pharmaceuticals LP | $508.26 | 2019-2025 | Farxiga |
| Lilly USA, LLC | $385.80 | 2019-2025 | Jardiance, Mounjaro, Lyumjev |
| Dexcom, INC. | $347.09 | 2021-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $338.56 | 2019-2025 | |
| Corcept Therapeutics | $337.88 | 2024-2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $293.48 | 2022-2025 | |
| Cequr Corporation | $278.92 | 2022-2025 | Cequr Simplicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $246.07 | 2019-2023 | Jardiance |
| Beta Bionics, INC. | $212.19 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Merck Sharp & Dohme LLC | $181.65 | 2019-2022 | |
| Insulet Corporation | $164.13 | 2019-2025 | Omnipod |
| Companion Medical, INC. | $153.39 | 2019-2020 | |
| Mannkind Corporation | $102.74 | 2023-2024 | Afrezza |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cathlyn Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.